rs201061621
Variant summary
Our verdict is Uncertain significance. Variant got 4 ACMG points: 4P and 0B. PM1PM2
The NM_000053.4(ATP7B):c.2921C>T(p.Thr974Met) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.000371 in 1,614,092 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Uncertain significance (★★). Synonymous variant affecting the same amino acid position (i.e. T974T) has been classified as Likely benign.
Frequency
Consequence
NM_000053.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 4 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
ATP7B | NM_000053.4 | c.2921C>T | p.Thr974Met | missense_variant | 13/21 | ENST00000242839.10 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
ATP7B | ENST00000242839.10 | c.2921C>T | p.Thr974Met | missense_variant | 13/21 | 1 | NM_000053.4 | P1 |
Frequencies
GnomAD3 genomes ? AF: 0.000276 AC: 42AN: 152246Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.000144 AC: 36AN: 249450Hom.: 0 AF XY: 0.000140 AC XY: 19AN XY: 135348
GnomAD4 exome AF: 0.000381 AC: 557AN: 1461846Hom.: 0 Cov.: 32 AF XY: 0.000363 AC XY: 264AN XY: 727222
GnomAD4 genome ? AF: 0.000276 AC: 42AN: 152246Hom.: 0 Cov.: 33 AF XY: 0.000229 AC XY: 17AN XY: 74384
ClinVar
Submissions by phenotype
Wilson disease Uncertain:8Other:1
Uncertain significance, criteria provided, single submitter | clinical testing | All of Us Research Program, National Institutes of Health | Feb 05, 2024 | This missense variant replaces threonine with methionine at codon 974 of the ATP7B protein. Computational prediction suggests that this variant may have deleterious impact on protein structure and function (internally defined REVEL score threshold >= 0.7, PMID: 27666373). To our knowledge, functional studies have not been reported for this variant. This variant has been reported in individuals affected with Wilson disease (PMID: 18373411, 27935710, 30097039). In one of these individuals, this variant was reported in the compound heterozygous state (PMID: 27935710). This variant has been identified in 46/280856 chromosomes in the general population by the Genome Aggregation Database (gnomAD). The available evidence is insufficient to determine the role of this variant in disease conclusively. Therefore, this variant is classified as a Variant of Uncertain Significance. - |
Uncertain significance, criteria provided, single submitter | clinical testing | Fulgent Genetics, Fulgent Genetics | May 16, 2022 | - - |
Uncertain significance, criteria provided, single submitter | clinical testing | Illumina Laboratory Services, Illumina | Apr 27, 2017 | This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). Publications were found based on this search. However, the evidence from the literature, in combination with allele frequency data from public databases where available, was not sufficient to rule this variant in or out of causing disease. Therefore, this variant is classified as a variant of unknown significance. - |
Uncertain significance, criteria provided, single submitter | clinical testing | Genome-Nilou Lab | Sep 05, 2021 | - - |
Uncertain significance, criteria provided, single submitter | clinical testing | ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories | Sep 20, 2022 | The ATP7B c.2921C>T; p.Thr974Met variant (rs201061621) has been described in an individual with a clinical diagnosis of Wilson disease (Davies 2008). The variant is reported in the ClinVar (Variation ID: 289465) and is listed in the general population with an overall allele frequency of 0.016% (46/280856 alleles) in the Genome Aggregation Database. The threonine at codon 974 is moderately conserved, occurs in the ATPase domain, and computational analyses predict that this variant is deleterious (REVEL: 0.746). Additionally, other variants in threonines in this region (p.Thr935Met, p.Thr977Met) are considered pathogenic. However, given the lack of clinical and functional data, the significance of the p.Thr974Met variant is uncertain at this time. References: Davies LP et al. New mutations in the Wilson disease gene, ATP7B: implications for molecular testing. Genet Test. 2008 Mar;12(1):139-45. PMID: 18373411. - |
Uncertain significance, no assertion criteria provided | clinical testing | Natera, Inc. | Sep 16, 2020 | - - |
Uncertain significance, criteria provided, single submitter | clinical testing | Invitae | Aug 21, 2022 | This sequence change replaces threonine, which is neutral and polar, with methionine, which is neutral and non-polar, at codon 974 of the ATP7B protein (p.Thr974Met). This variant is present in population databases (rs201061621, gnomAD 0.03%). This variant has not been reported in the literature in individuals affected with ATP7B-related conditions. ClinVar contains an entry for this variant (Variation ID: 289465). Algorithms developed to predict the effect of missense changes on protein structure and function are either unavailable or do not agree on the potential impact of this missense change (SIFT: "Deleterious"; PolyPhen-2: "Probably Damaging"; Align-GVGD: "Class C15"). Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may create or strengthen a splice site. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. - |
not provided, no classification provided | phenotyping only | GenomeConnect, ClinGen | - | GenomeConnect assertions are reported exactly as they appear on the patient-provided report from the testing laboratory. GenomeConnect staff make no attempt to reinterpret the clinical significance of the variant. - |
Uncertain significance, criteria provided, single submitter | clinical testing | Counsyl | Mar 03, 2017 | - - |
not provided Uncertain:4
Uncertain significance, criteria provided, single submitter | clinical testing | Mayo Clinic Laboratories, Mayo Clinic | Aug 23, 2021 | - - |
Uncertain significance, criteria provided, single submitter | clinical testing | Eurofins Ntd Llc (ga) | Jul 22, 2016 | - - |
Uncertain significance, criteria provided, single submitter | clinical testing | GeneDx | Dec 07, 2020 | Reported previously in an individual with a reported diagnosis of Wilson disease; however, further phenotypic information was not provided, and it is unclear whether or not this individual also harbored a second ATP7B variant (Davies et al., 2008); Reported in an individual with alcoholic liver cirrhosis whose biochemistry did not support a diagnosis of Wilson disease (Jung et al., 2016); In silico analysis, which includes protein predictors and evolutionary conservation, supports a deleterious effect This variant is associated with the following publications: (PMID: 30097039, 18373411, 27935710, 22692182) - |
Uncertain significance, criteria provided, single submitter | clinical testing | Greenwood Genetic Center Diagnostic Laboratories, Greenwood Genetic Center | Dec 19, 2022 | PP3 - |
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Women's Health and Genetics/Laboratory Corporation of America, LabCorp | Jan 18, 2024 | Variant summary: AATP7B c.2921C>T (p.Thr974Met) results in a non-conservative amino acid change located in the transmembrane 6 region, could affect protein conformation, as other variants (DVs) in this domain have been shown to do, or disrupt the transport of copper across the lipid bilayer. However, there are currently no studies to support such predictions. Four of five in-silico tools predict a damaging effect of the variant on protein function. The variant allele was found at a frequency of 0.00014 in 249500 control chromosomes (gnomAD and publication data). This frequency is not significantly higher than estimated for a pathogenic variant in ATP7B causing Wilson Disease (0.00014 vs 0.0054), allowing no conclusion about variant significance. c.2921C>T has been reported in the literature in individuals affected with Wilson Disease (examples: Davies_2008, Jung_2017). These data do not allow any conclusion about variant significance. The following publications have been ascertained in the context of this evaluation (PMID: 30097039, 18373411, 27935710, 23235335, 20465995, 31449670, 22692182, 31059521, 24253677, 31751128). ClinVar contains an entry for this variant (Variation ID: 289465). Based on the evidence outlined above, the variant was classified as uncertain significance. - |
Inborn genetic diseases Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Apr 15, 2021 | Identified in one patient with Wilson disease; however, no second ATP7B variant was reported (Davies, 2008)_x000D_ _x000D_ Studies of evolutionary conservation and structure were inconclusive regarding the effect of this alteration on protein function (Schushan, 2012) Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at